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A B S T R A C T
Purpose: Epilepsy surgery is the most efﬁcacious therapeutic modality for patients with medically
refractory focal epilepsies, but surgical failures remain a challenge to the epilepsy treatment team. The
aim of present study was to evaluate the postoperative outcome of patients who underwent reoperation
after a failed epilepsy surgery on the temporal lobe.
Methods: We systematically analyzed the results of comprehensive preoperative evaluations before the
ﬁrst surgery, and before and after reoperation in 17 patients with drug resistant temporal lobe epilepsies.
Results: Overall, 13 of 17 patients (76.5%) improved after reoperation: ﬁve patients (29.4%) were
completely seizure free after reoperation (median duration 60 months, range 12–72); six patients
(35.3%) were seizure free at least 12 month before observation points (median duration 120.5 months,
range 35–155) and two patients (11.8%) had a decrease in seizure frequency. Four patients (23.5%)
remained unchanged with respect to seizure frequency and severity. There was no correlation between
the improvement in seizure outcome after reoperation and other clinical data except of the history of
traumatic brain injury (TBI). The patients who had no history of TBI improved after reoperation,
compared to patients with TBI (p = 0.044). The postoperative seizure outcome of patients with
incongruent Video-EEG results before the ﬁrst surgery (p = 0.116) and before reoperation (p = 0.622) was
not poorer compared to patients with congruent Video-EEG results.
Conclusions: Reoperation can considerably improve the operative outcome of the ﬁrst failed epilepsy
surgery in patients with drug resistant temporal lobe epilepsies. Epilepsy centres should be encouraged
to report the results of failed epilepsy surgeries.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Temporal lobe epilepsy (TLE) is the most frequent and drug-
resistant syndrome among the refractory focal epilepsy syn-
dromes. Over the last few decades epilepsy surgery has proved to
be a successful and effective method for the treatment of patients
with medically refractory temporal lobe epilepsy providing 60–
70% freedom from disabling seizures.1 The aim of surgical
treatment is to achieve seizure freedom with the smallest possible
postsurgical neuropsychological deﬁcit.
In many epilepsy centres selective amygdalohippocampectomy
via the transsylvian route was established as a common surgical* Corresponding author at: Department of Neurology, Medical University of
Vienna, Spitalgasse 23, 1090 Vienna, Austria. Tel.: +43 140400 3433;
fax: +43 140400 3141.
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http://dx.doi.org/10.1016/j.seizure.2012.11.011procedure for treatment of temporal lobe epilepsies2 since it
appears to have more favourable cognitive outcome compared
with standard anterior temporal lobectomy.3,4 However, restric-
tive operation types can reduce the efﬁciency of seizure control.
Insufﬁcient removal of the epileptogenic zone, multifocal epileptic
discharges caused by an extended network within the ipsilateral
hemisphere5 or an independent contralateral temporal epilepto-
genic zone 6 can lead to an unsatisfying outcome after epilepsy
surgery. Up to 40% of the patients relapse, either immediately or at
a later time after surgery.6,7 A reoperation using an extended
resection type, like anteromedial temporal lobectomy, can be a
treatment option for patients with persistent seizures postopera-
tively.
The aim of the present study was to examine the postoperative
outcome in temporal lobe epilepsy patients who underwent
reoperation after a failed epilepsy surgery. We systematically
analyzed the results of comprehensive preoperative evaluations
(demographic data, ictal and interictal discharges on scalp EEG,vier Ltd. All rights reserved.
Table 1
Postoperative outcome of 336 patients with TLE after sAHE, AMT and TR.
Free of disabling seizures Not seizure-free Sum
sAHE 109 (74.7%) 37 (25.3%) 146
AMT 80 (70.8%) 33 (29.9%) 113
TR 55 (71.4%) 22 (28.6%) 77
Sum 244 (72.6%) 92 (27.4%) 336
TLE, temporal lobe epilepsy; sAHE, selective amygdalohippocampectomy; TR,
tailored resection; free of disabling seizures, ILAE classiﬁcation; Class 1a, Class 1 and
Class 2; not seizure-free, ILAE classiﬁcation, Classes 3–6.
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ical test-results) before the ﬁrst surgery, and before and after
reoperation. In addition, we attempted to determine what factors,
if any, might predict a successful outcome after reoperation.
2. Methods
2.1. Patients
We retrospectively analyzed the data of patients who were
evaluated and operated at our institution between 1993 and 2010.
The inclusion criteria were medically intractable temporal lobe
epilepsy, no evidence of malignant brain tumour and a follow-up
period for outcome classiﬁcation of at least 12 months.
Between December 1993 and December 2011, 487 surgical
interventions for the management of epilepsy were performed at
our institution. Three hundred and thirty six patients (152 male,
184 female) underwent resective epilepsy surgery for medically
refractory TLE, 146 patients underwent selective amygdalohippo-
campectomy (sAHE), 113 patients had anteromedial temporal
lobectomy (AMT) and 77 had tailored temporal lobe resection (TR).
Two hundred and forty four patients (72.6%) were free of
disabling seizures (Class 1a to Class 2 according to Wieser’s
classiﬁcation8) at least 12 month before observation points.
All patients who had persistent seizures after the ﬁrst epilepsy
surgery (Class 3–Class 5 according to Wieser’s classiﬁcation) were
offered a re-evaluation and, if possible, reoperation. We excluded
from further analysis patients who refused re-evaluation (47
patients), or reoperation (12 patients) and patients with incom-
plete data or lost follow-up (16 patients) data after reoperation. In
the end, 17 patients (6 male, 11 female) who underwent
reoperation after an extensive re-evaluation were included in
subsequent analyses. The protocol of the study was reviewed and
approved by local Ethics Committee.
2.2. Presurgical evaluation
All patients were subjected to extensive evaluation before
surgery. The presurgical work-up comprised neurologic examina-
tion and history, prolonged Video-EEG-monitoring, high resolution
magnetic resonance imaging (MRI), Wada-testing for assessment
of language and memory functions, formal neuropsychological
testing and visual ﬁeld examination using the standard automated
perimetry exam. In the majority of patients interictal single photon
emission computed tomography (SPECT) and interictal positron
emission tomography (PET) were performed.
Video-EEG-monitoring was recorded for an average of 5 days;
the EEG was recorded according to the extended International 10–
20 System including bilaterally placed sphenoidal electrodes.
Seizure semiology and clinical lateralizing signs during the
seizures were evaluated with respect to prediction of the side of
the epileptogenic zone.9 Absolute spike frequency and location of
interictal epileptiform discharges (IEDs) were assessed by visual
analyses over the entire recording time. The distribution of IEDs
was deﬁned as unilateral if >90% of spikes occurred over the
affected temporal lobe.10 Ictal scalp EEG patterns were determined
by morphology, location and time course of ictal EEG changes.11,12
The results of Video-EEG-monitoring were considered congruent if
the patient had ipsilateral unitemporal IEDs, ipsilateral temporal
ictal EEG patterns and clinical lateralizing signs corresponding to
ipsilateral temporal region or non-lateralizable signs clearly
corresponding to temporal lobe origin, i.e. oral automatisms,
behavioural arrest, etc. The results were considered incongruent if
one of the following was applicable: IED distribution was
bitemporal or predominantly contralateral, ictal EEG patternscould not be clearly localized over the affected temporal lobe and
the clinical ictal semiology was lateralized to contralateral side.
All patients underwent a high-resolution MRI scan using a 1.5 T
machine (Philips Gyroscan ACS-NT; Best the Netherlands). Starting
from 2006 MRI was carried out on a 3.0 T machine. A temporal lobe
protocol was applied for detailed depiction of temporal lobe
structures (guidelines for neuroimaging evaluation of patients
with uncontrolled epilepsy considered for surgery).13
2.3. Surgical procedure
Depending on the results of the comprehensive preoperative
evaluations, the patients were subjected to following surgical
procedures: selective amygdalohippocampectomy, anteromedial
temporal lobectomy or tailored temporal lobe resection. The
decision regarding the type of operation to be performed was made
individually for each patient after completing the presurgical
work-up and case discussion at a multidisciplinary epilepsy
conference. All surgeries were done by one neurosurgeon (T.C.)
between 1993 and 2010. The resected tissue was sent for
histopathological analyses in all cases.
2.4. Postoperative outcome
The postoperative follow-up was assessed one, two, ﬁve and
10 years postoperatively. It included neurological examination,
scalp EEG, MRI, neuropsychological testing and visual ﬁeld
examination. In addition, the seizure outcome was evaluated
yearly based on telephone interviews. The outcome was scored
using the stringent classiﬁcation of the International League
Against Epilepsy.8
Overall from 336 operated patients 244 patients (72.6%) were
free of disabling seizures (ILAE Classes 1a, 1 and 2): 109 patients
with sAHE (74.7%), 80 patients with AMT (70.8%) and 55 patients
with TR (71.4%). These results are presented in Table 1. The
patients who failed after the ﬁrst operation were offered a re-
evaluation according to criteria described above and, if possible, a
reoperation. Again, the decision regarding the type of reoperation
to be performed was made individually after completing the
reevaluation and case discussion at a multidisciplinary epilepsy
conference. After the reoperation the patients were subjected to
postoperative follow-up using the same criteria that were used
after the initial operation.
2.5. Analysis of the data of reoperated patients
Only reoperated patients were included in subsequent analysis.
We preformed an analysis of different variables in order to assess
prognostic signiﬁcance and to ﬁnd the best predictors for
successful outcome. These variables included history of febrile
seizures, TBI, infectious brain diseases, perinatal pathology,
morphological changes on MRI, concordance of results of Video-
EEG-monitoring with side of operation, type and extent of
operation and histopathology.
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commercially available statistical software (SPSS 19.0; Chicago,
IL). Demographic and clinical characteristics of patients were
compared using Fisher’s exact tests for ordinal and two-sided
Students’ t-tests for metrical data. The level of signiﬁcance was set
to p < 0.05.
3. Results
The clinical data of the 17 reoperated patients are summarized
in the Table 2. The mean age at seizure onset was 9.4 years (range
0.1–36 years; median 6 years), the mean duration of epilepsy was
21.7 years (range 5–48 years; median 20.9 years) and the mean
age at ﬁrst operation was 31.1 years (range 16–61 years; median
29 years). Two patients without morphological changes on MRI
before ﬁrst operation (patients #4 and #6) underwent invasive
evaluation. The seizures reoccurred immediately after ﬁrst
operation in all patients except of one patient (patient #8) in
whom the seizures occurred 12 month after ﬁrst operation. There
was no change in antiepileptic drug regimen after ﬁrst operation.
The antiepileptic drugs were kept stable at least 12 month after
operation. The mean age at the time of reoperation was 35.5 years
(range 18–65 years; median 34 years).
Overall, 13 of 17 patients (76.5%) improved after reoperation:
ﬁve patients (29.4%) were completely seizure free after reoperation
(Class 1a) (median duration 60 months, range 12–72); six patients
(35.3%) were seizure free at least 12 month before observation
points (median duration 120.5 months, range 35–155) and two
patients (11.8%) had a decrease in seizure frequency. Four patients
(23.5%) remained unchanged with respect to seizure frequency
and severity (Table 3).
Patients who had no history of TBI improved after reoperation,
compared to patients who had a history of TBI (p = 0.044). There
was no correlation between improvement in seizure outcome after
reoperation and the following variables: gender (p = 0.999),
handedness (p = 0.426), positive family history for epilepsy
(p = 0.538), history of perinatal complications (p = 0.999), history
of infection (p = 0.584), history of febrile seizures (p = 0.261),
morphological changes on MRI before ﬁrst operation (p = 0.643),
age at initial operation (p = 0.648) and at reoperation (p = 0.743),
type of operation for ﬁrst surgery (sAHE vs. TR, p = 0.825) and
reoperation (sAHE vs. AMT, p = 0.567), histopathological results of
ﬁrst operation (p = 0.76) and reoperation (p = 0.175). Postoperative
seizure outcome of patients with incongruent Video-EEG results
before the ﬁrst surgery (p = 0.116) and before reoperationTable 2
Demographic data of patients.
ID Age/sex Age at seizure
onset (years)
Childhood
risk factors
Handedness F
f
# 1 61/m 13 0 Right N
# 2 40/f 0.5 TBI, M/E Right P
# 3 16/m 10 TBI, M/E Right N
# 4 29/f 6 0 Left N
# 5 34/f 15 FS Right N
# 6 25/m 1 0 Right P
# 7 20/m 1 M/E Left N
# 8 36/m 31 0 Right N
# 9 21/f 14 0 Right N
# 10 30/f 1 M/E Right N
# 11 27/m 0.5 0 Right N
# 12 44/f 1 FS Right N
# 13 45/f 36 M/E, FS Right N
# 14 24/f 8 0 Right N
# 15 21/f 0.1 FS Right P
# 16 30/f 22 0 Right P
# 17 26/f 0.5 M/E, FS Right P
m, male; f, female; TBI, traumatic brain injury; M/E, meningitis/encephalitis; FS, febril(p = 0.622) was not poorer compared to patients with congruent
Video-EEG results. Two patients with congruent Video-EEG-
monitoring results before ﬁrst operation developed bilateral spike
distribution after surgery. This resulted in the incongruent Video-
EEG-monitoring results before reoperation. Patient #6 had
bilateral spike distribution with 18% interictal spikes localized
to contralateral temporal lobe and patient #17 had 29% of interictal
spikes on the contralateral temporal lobe. The ictal EEG patterns
and clinical semiology were congruent to side of operation
(Supporting information 1).
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.seizure.2012.11.011.
We also analyzed the neuropsychological test results before
and after surgery, and after reoperation. The patients were
administered standardized neuropsychological tests prior to
surgery, 38 months mean (range from 3 to 96 months) post-
operatively and again 49 months mean (range from 9 to 120) after
reoperation. Only tasks that were administered to most of the
patients were included. Although the majority of patients received
a similar battery of tests, there were some discrepancies. This was
due to varying presenting cognitive complaints at the time of
testing and alterations in the standard test battery over the 15-year
period. For this reason the presented results are rather descriptive.
Patients who were seizure-free after reoperation tended to score
higher on HAWIE Verbal and Performance IQ measures than those
who were not seizure-free (p = 0.018). Mean IQ scores for both
patient groups, however, fell within the average range. The
seizure-free patients tended to perform better on verbal ﬂuency
tests (p = 0.009) although reliable between-group statistical
comparisons of mean scores were not possible due to small and
unequal sample sizes (Supporting information 2).
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.seizure.2012.11.011.
4. Discussion
Epilepsy surgery is the most efﬁcacious therapeutic modality
for patients with medically refractory focal epilepsies. Ideal
candidates for epilepsy surgery are patients with mesial TLE with
ipsilateral spikes, seizure onset pattern, clinical lateralizing signs
and atrophy of mesial structures on MRI.14,15 Nevertheless,
surgical failures remain a challenge to the epilepsy treatment
team with long term seizure-free outcome and success ratesamily history
or epilepsy
Lesion on MRI Epilepsy duration
(years)
egative Lesion in amygdala right 48
ositive HA/S left 40
egative HA/S right 6
egative Normal 23
egative HA/S right 19
ositive Normal 24
egative HA/S and lesion temporal basal left 19
egative Cavernoma mesial temporal right 5
egative Lesion in amygdala left 7
egative HA/S left 29
egative HA/S left 27
egative HA/S right 43
egative HA/S right 9
egative HA/S right 16
ositive HA/S left 21
ositive Cystic lesion mesial temporal right 8
ositive HA/S left 26
e seizures; HA/S, hippocampal atrophy/sclerosis.
Table 3
Results of Video-EEG monitoring, surgery and postoperative outcome.
ID V-EEG before
1st
surgery
Side of
operation
Type of
1st
surgery
Pathology
1st
surgery
Outcome
1st
surgery
FU period
after 1st
surgery (m)
V-EEG-before
2nd
surgery
Type of
2nd
surgery
Pathology
2nd
surgery
Outcome
2nd
surgery
FU period
after 2nd
surgery (m)
# 1 Congruent Right TR Gliosis Class 4 46 Congruent AMT Gliosis Class 1a 72
# 2 Incongruent Left sAHE HA/S Class 4 31 Incongruent AMT Gliosis Class 3 121
# 3 Incongruent Right sAHE HA/S Class 5 17 Congruent AMT HA/S Class 5 23
# 4 Congruent Left sAHE Gliosis Class 5 125 Congruent AMT Gliosis Class 5 12
# 5 Congruent Right sAHE Not available Class 5 93 Congruent AMT Gliosis Class 1a 59
# 6 Congruent Right sAHE HA/S Class 3 50 Incongruent AMT Gliosis Class 1 35
# 7 Incongruent Left TR Low grade glioma Class 4 32 Congruent AMT No changes Class 1 116
# 8 Incongruent Right TR Cavernoma Class 4 91 Incongruent sAHE Gliosis Class 1a 24
# 9 Congruent Left TR Not available Class 5 59 Congruent AMT no changes Class 2 70
# 10 Incongruent Left sAHE HA/S Class 4 49 Incongruent AMT Gliosis Class 1 121
# 11 Congruent Left sAHE HA/S Class 4 42 Congruent AMT HA/S Class 1a 70
# 12 Congruent Right sAHE HA/S Class 4 60 Congruent AMT Gliosis Class 1a 60
# 13 Incongruent Right sAHE HA/S Class 4 23 Incongruent AMT Gliosis Class 1 124
# 14 Congruent Right sAHE HA/S Class 5 11 Congruent AMT Gliosis Class 1 155
# 15 Congruent Left sAHE HA/S Class 3 71 Congruent AMT Gliosis Class 2 62
# 16 Incongruent Right TR Epidermoid Class 3 64 Congruent AMT HA/S and
epidermoid
Class 3 42
# 17 Congruent Left sAHE Not available Class 5 18 Incongruent AMT Gliosis Class1 120
sAHE, selective amygdala-hippocampectomy; AMT, anteromesial resection; TR, tailored resection; HA/S, hippocampal atrophy/sclerosis; V-EEG, Video-EEG-monitoring.
R. Jung et al. / Seizure 22 (2013) 502–506 505ranging from 45% (ﬁve years outcome) to 70%.1,7,16–18 Our ﬁndings
indicate that reoperation can considerably improve the operative
outcome of the ﬁrst failed epilepsy surgery in patients with drug
resistant temporal lobe epilepsies. While many epilepsy centres
have started to report their experience with the management of
recurrent seizures and reoperation after failure of initial surgery,
19–25 there remains a lack of information about outcome data in the
literature and reoperation still remains rare in epilepsy surgery.
The present study also attempted to determine prognostic
factors in failed temporal lobe epilepsy surgeries. After systematic
analyses of the results of comprehensive evaluation before the ﬁrst
surgery and before and after reoperation we found that patients
who improved after reoperation had no history o f TBI compared to
patients who did not improve (p = 0.044). Although the signiﬁ-
cance of this ﬁnding remains unknown, it may suggest that
traumatic brain injury could cause spatial extension of the
epileptogenic zone. Due to very small number of patients these
results should be treated with caution.
Other predictors of postoperative seizure outcome have been
discussed in recent publications. Anatomically and electrographi-
cally non-localized seizure onset before the ﬁrst operation has
been considered a negative predictor for reoperation recommend-
ing palliative procedures unless there is compelling evidence that
reoperation will be successful.23 Schulz et al. discuss an association
between ictal scalp EEG with secondary contralateral independent
EEG seizure propagation patterns, small quantity of lateral
temporal lobe resection and non-favourable outcome after second
surgery in patients with mesial TLE.22 This suggests that the
remaining epileptogenc tissue near the anterior or posterior
hippocampal commissures and propagation of epileptic activity
could be a possible reason for contralateral EEG propagation that
may result in a non-favourable outcome. This hypothesis can be
conﬁrmed only by using invasive Video-EEG monitoring, which is
the ‘gold standard’ for deﬁning the epileptogenic zone. Although
we did not use invasive monitoring in patients before reoperation,
the postoperative seizure outcome of patients with incongruent
Video-EEG results before the ﬁrst surgery (p = 0.116) and before
reoperation (p = 0.622) was not poorer compared to patients with
congruent Video-EEG results. Additional studies using invasive
Video-EEG monitoring would be required to strengthen these
ﬁndings.
We did not ﬁnd any correlation of other investigated
demographic and clinical data (sex, handedness, positive familyhistory for epilepsy, history of infection, history of febrile seizures,
age at the ﬁrst operation and at reoperation, type of operation for
ﬁrst operation (sAHE vs. TR) and reoperation (sAHE vs. AMT),
histopathological results of ﬁrst operation and reoperation) with
postoperative seizure-freedom after reoperation.
Even though our centre was established 1993 when preopera-
tive structural imaging using MRI was a standard procedure in
phase I of evaluation, we do not exclude the possibility that our
series of patients could have had an inadequate resection at the
time of the ﬁrst surgery. The results of MRI analysis of the
reoperated patients are already presented in a previous study,
showing residual mesiotemporal structures in the majority of
patients who became seizure free after reoperation.25 Nevertheless
in our series of 336 patients operated on temporal lobe the seizure
outcome of patients with sAHE is even slightly better in
comparison to large resections: 74.7% of patients with sAHE,
70.8% of patients with AMT and 71.4% of patients with TR are free of
disabling seizures postoperatively. The philosophy of our centre is
to restrict the resection to the smallest possible area to reduce the
chance of postoperative neuropsychological deﬁcits.3
The aim of present study was an attempt to persuade for
proceeding to reoperation after failure of ﬁrst operation. Encour-
aging are also the results of neuropsychological testing showing
that patients who were seizure-free after reoperation tended to
score higher on HAWIE Verbal and Performance IQ measures than
those that were not seizure-free (p = 0.018). The seizure-free
patients tended to perform better on verbal ﬂuency tests
(p = 0.009) although reliable between-group statistical compar-
isons of mean scores were not possible due to small and unequal
sample sizes.
Our overall seizure-free outcome of reoperated patients of
64.7% is higher in comparison to previously published studies,
where the rate of seizure-free patients ranged from 19 to 57%.20–24
This could be due to our very careful selection of patients with
regard to localization and type of lesion. The majority of previous
studies included different aetiologies of epilepsies (lesional and
non-lesional) and mostly mixed localization (temporal and
extratemporal cases). Moreover, other studies focused on the
neurosurgical approach to deﬁne and resect residual mesial
temporal lobe structures and in some cases a corpus callosotomy
or even VNS were considered a reoperation.20–24
To our knowledge this is the ﬁrst study with systematic
analyses of reoperated patients with temporal lobe epilepsies, who
R. Jung et al. / Seizure 22 (2013) 502–506506mostly underwent sAHE or tailored very restricted AMT during the
ﬁrst operation. Although the search for clinical predictors of
surgical failures has shown limited success, our study demon-
strated that a favourable outcome appeared in patients without
TBI. Even though our sample size is small, these initial results are
very promising.
5. Conclusions
Overall 76.5% of patients (13 of 17) in our series improved after
further surgery. Our data conﬁrm prior literature suggesting that a
reoperation may result in a considerable improvement of the
operative outcome of the ﬁrst failed epilepsy surgery. Epilepsy
centres should be encouraged to report the results of failed
epilepsy surgery.
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